Dr. Chong is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8613 Route 29 Ste 200n
Fairfax, VA 22031Phone+1 715-350-8400Fax+1 703-280-9596
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Medical College of GeorgiaChief Residency, Internal Medicine, 2012 - 2013- Medical College of GeorgiaResidency, Internal Medicine, 2008 - 2011
University of Virginia School of MedicineClass of 2008
Certifications & Licensure
CA State Medical License 2011 - Present
VA State Medical License 2015 - 2026
GA State Medical License 2011 - 2012- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 103 citationsTargeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.Ramesh Balusu, Warren Fiskus, Rekha Rao, Daniel G. Chong, Srilatha Nalluri
Blood. 2011-09-15 - 40 citationsPan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists.Aditya Mandawat, Warren Fiskus, Kathleen M. Buckley, Kelly Robbins, Rekha Rao
Blood. 2010-12-09 - 149 citationsCotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloprolife...Yongchao Wang, Warren Fiskus, Daniel G. Chong, Kathleen M. Buckley, Kavita Natarajan
Blood. 2009-12-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
